Therefore, determining the level of PEDF in a tumour or the serum at the time of diagnosis could be an excellent source of information for delineating more or less aggressive treatment protocols to improve the therapeutic outcomes in cancer patients [60,120,126]. Here, SERPINF1 is linked to neoplasm.